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Summary
Relaxin is involved in a variety of functions. Among them, relaxin infl uences gastrointesti-
nal motility in mice mainly regulating the biosynthesis of nitric oxide, considered as the main 
substance causing smooth muscle relaxations. Relaxin is able to regulate the diff erent nitric 
oxide synthase expression depending on the gut region considered. Relaxin also counteracts 
the hypermotility state, related to a defective nitric oxide production, observed in the gut of 
dystrophic (mdx) mice.
From the above considerations, it appears that relaxin, in addition to its physiological roles, 
may be regarded as a therapeutic tool in gastrointestinal diseases characterized pathogenically 
by an altered nitric oxide production.
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The possibility that relaxin (RLX) might be involved in the control of gastrointes-
tinal motility by regulating nitric oxide (NO) biosynthesis, as it does in other smooth 
muscle target organs (3), was investigated. 
Mechanical experiments have shown that RLX infl uenced gastrointestinal motility 
in female mice through a NO-mediated mechanism acting at the neurotransmission 
or at the muscular level depending on the gut segment considered (1,2,4). In agree-
ment, immunohistochemical results, showed that RLX regulates, in a selective man-
ner, the expression of the diff erent nitric oxide synthase (NOS) isoforms (Table 1). 
RLX-induced decrease of small bowel motility may play a physiological role during 
pregnancy directed to increase the intestinal transit time, so favoring the absorption 
of nutrients. The increased contractile activity of the colonic muscle by RLX could be 
aimed at facilitating absorption of a major quantity of water by a continuous mixing 
of the content, so contributing to constipation, the main symptom in pregnancy. 
Besides its physiological role, the possibility that RLX may also have some bene-
fi cial eff ects in those gastrointestinal motor alterations related to a defective NO pro-
duction, such as those reported in the dystrophic (mdx) mice, was investigated. 
Functional experiments showed that RLX was able, through a NO-mediated 
mechanism, to reverse the altered gastrointestinal motor responses in preparations 
from mdx male mice (1,4). Of note, in mdx mice, the hormone appeared to compen-
sate for the NO defect until a normal motility has been restored. In keeping, immu-
nohistochemical experiments showed that RLX up-regulated the expression of only 
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those NOS that resulted defective in the mdx preparations (i.e. nNOS and iNOS in 
gastric and ileal preparations, respectively) . 
Table 1. Modulation of NO generation by RLX in the gastrointestinal tract of mice
Gatrointestinal 
tract Model
Evidence for 
NO production
NO synthase  
regulation Biological effects
Gastric fundus ex vivoin vivo
NOS inhibition
(L-NNA)
 nNOS (protein)
 eNOS (protein)
Decreased motility, 
normalization of hypermotility
Ileum ex vivoin vivo
NOS inhibition
(L-NNA)
 iNOS (protein)
  eNOS (protein)
Decreased motility, 
normalization of hypermotility
Proximal colon ex vivo NOS inhibition(L-NNA)
 nNOSß (protein)
¯nNOSα (protein)
¯ eNOS (protein)
Decreased basal tension, 
increased spontaneous 
contractions
In conclusion, RLX influences gastrointestinal motility mainly regulating, in a 
selective manner, the expression of the different NOS isoforms. Thus, even though 
caution is needed in extrapolating data obtained in animals to humans, may be 
regarded as a potential tool in the therapeutic approach to gastrointestinal motor dis-
orders caused by altered NO production.
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